preimpianto

Preimpianto refers to a set of medical procedures performed before an embryo is transferred into the uterus during in vitro fertilization (IVF). The primary goal of preimpianto is to increase the chances of a successful pregnancy and reduce the risk of certain genetic or chromosomal abnormalities in the resulting child.

One key technique within preimpianto is preimplantation genetic testing (PGT). PGT allows for the screening of embryos for specific genetic disorders, such as cystic fibrosis or Huntington's disease, as well as chromosomal abnormalities like Down syndrome. This involves removing a few cells from the embryo for analysis. Based on the results, embryos that are deemed chromosomally normal or free of the targeted genetic conditions can be selected for transfer.

Another aspect of preimpianto can include embryo biopsy, the procedure for obtaining cells for PGT. Embryo development is closely monitored during this stage, and only the healthiest-looking embryos are typically considered for biopsy and further testing. The process requires specialized laboratory techniques and highly trained personnel.

The decision to undergo preimpianto procedures is usually made in consultation with a fertility specialist and a genetic counselor. It is often recommended for individuals or couples with a known history of genetic disorders, advanced maternal age, or recurrent implantation failures. While preimpianto offers potential benefits, it is also associated with additional costs and ethical considerations.